These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2978901)

  • 1. Cyclosporine sensitivity of human alloreactive T lymphocytes depends on the strength of the allogeneic stimulus.
    Kunkl A; Fenoglio D; Manca F; Caltabellotta M; Barocci S; Carozzi S; Valente U; Gessaga M; Celada F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):262. PubMed ID: 2978901
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine A treatment induces changes in CD45R (restricted common leukocyte antigen) expression in the mixed lymphocyte reaction.
    Stein-Oakley AN; Kraft NE; Hutchinson P; Thomson NM
    Transplant Proc; 1989 Oct; 21(5):3759-60. PubMed ID: 2530675
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine inhibits interleukin-2 production during human cellular immune response to pig antigens.
    Pozzetto U; Citterio F; Fioravanti G; Tassoni S; Serino F; Caizzi MP; Castagneto M
    Transplant Proc; 1994 Oct; 26(5):2869-70. PubMed ID: 7940906
    [No Abstract]   [Full Text] [Related]  

  • 5. Gangliosides potentiate cyclosporine A-induced suppression of allospecific immune responses.
    Spagnoli GC; Ausiello CM; Sconocchia G; Adorno D; Casciani CU
    Transplant Proc; 1991 Feb; 23(1 Pt 1):342-5. PubMed ID: 1824985
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes.
    Ryffel B; Müller S; Foxwell B
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1199-201. PubMed ID: 3079016
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes.
    Buurman WA; Daemen AJ; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1193. PubMed ID: 3152624
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclosporine A (CyA) on secreted T proteins from T lymphocytes stimulated by PMA/calcium ionophore.
    Bigot E; Soulillou JP; Naulet J; Jacques Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):245-7. PubMed ID: 1990523
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine A modulates the proliferation of T-lymphocyte colony forming cell subpopulations.
    Tice DG; Reinitz ER
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1191-2. PubMed ID: 3274305
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin A prevents the appearance of cell surface "activation" antigens.
    Leapman SB; Strong DM; Filo RS; Smith EJ; Brandt GL
    Transplantation; 1982 Aug; 34(2):94-5. PubMed ID: 6215747
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation.
    Helin HJ; Edgington TS
    J Immunol; 1984 Mar; 132(3):1074-6. PubMed ID: 6229574
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro comparison of human xenogeneic and allogeneic proliferative cellular immune responses using serum-free media.
    Saetre AM; Lillevang ST; Kemp E; Kristensen T
    Transplant Proc; 1996 Apr; 28(2):656-7. PubMed ID: 8623329
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.
    Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ
    Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
    MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of action of cyclosporin A].
    Wagner H; Hardt C; Heeg K
    Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.